Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ELOCTATE DIN 02430320

Status: Marketed
Holder: SANOFI-AVENTIS CANADA INC
Molecule: ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN

Health Canada record

Active ingredient(s)ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN 1000 UNIT
Dosage formKit; Powder For Solution
RouteIntravenous
ScheduleSCHEDULE D
ClassHuman
ATCB02BD02 COAGULATION FACTOR VIII
Original market date15-Jan-2016
Current status date03-Nov-2021
SourceHealth Canada DPD

Establishment licence of the holder

sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN

DINProductCompanyFormStrengthStatus
02430290ELOCTATESANOFI-AVENTIS CANADA INCKit; Powder For SolutionANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN 250 UNITMarketed
02430304ELOCTATESANOFI-AVENTIS CANADA INCKit; Powder For SolutionANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN 500 UNITMarketed
02430312ELOCTATESANOFI-AVENTIS CANADA INCKit; Powder For SolutionANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN 750 UNITMarketed
02430339ELOCTATESANOFI-AVENTIS CANADA INCKit; Powder For SolutionANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN 1500 UNITMarketed
02430347ELOCTATESANOFI-AVENTIS CANADA INCKit; Powder For SolutionANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN 2000 UNITMarketed
02430355ELOCTATESANOFI-AVENTIS CANADA INCPowder For Solution; KitANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN 3000 UNITMarketed

Notices of Compliance

NOCDateSubmissionReason
193122017-05-17New Drug Submission (NDS)MERGER - BUYOUT
159912014-08-22New Drug Submission (NDS)
Request a quote for ELOCTATE

How to read a Canadian DIN record